Coxsackie-virus heart-disease

Corrigendum to "Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of <i>EGFR</i>-mutated advanced NSCLC patients": [ESMO Real World Data and Digital Oncology Volume 10, December 2025, 100198].

ESMO real world data and digital oncology·2026

Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.

ESMO real world data and digital oncology·2026

Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies.

Cancer treatment reviews·2025

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO).

ESMO open·2024

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

Open forum infectious diseases·2026

Long-Term Outcomes of Living-Related Kidney Donors Over 26 Years: A Study of 154 Cases From the Ibn Sina University Hospital Center in Rabat, Morocco.

Cureus·2026

The Role of Downstream Kynurenine Pathway Metabolites in the Modulation of Cardiovascular Disease Development in Chronic Kidney Disease.

International journal of tryptophan research : IJTR·2026

Association between Chinese herbal medicine and the composite outcome of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a prospective cohort study.

Journal of geriatric cardiology : JGC·2026

Health economic evaluation of left atrial appendage closure in patients with atrial fibrillation and at high risk for stroke and bleeding: a study protocol.

Frontiers in health services·2026

Hypertension and Postoperative Outcomes: A Retrospective Cohort Study.

Anesthesiology research and practice·2026

Related Experiment Videos

Coxsackie-virus heart-disease

Related Concept Videos

Corrigendum to "Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of <i>EGFR</i>-mutated advanced NSCLC patients": [ESMO Real World Data and Digital Oncology Volume 10, December 2025, 100198].

Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.

Angiogenesis and thymic epithelial tumors: from preclinical insights to different therapeutic lines and combination strategies.

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO).

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study.

Long-Term Outcomes of Living-Related Kidney Donors Over 26 Years: A Study of 154 Cases From the Ibn Sina University Hospital Center in Rabat, Morocco.

The Role of Downstream Kynurenine Pathway Metabolites in the Modulation of Cardiovascular Disease Development in Chronic Kidney Disease.

Association between Chinese herbal medicine and the composite outcome of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: a prospective cohort study.

Health economic evaluation of left atrial appendage closure in patients with atrial fibrillation and at high risk for stroke and bleeding: a study protocol.

Hypertension and Postoperative Outcomes: A Retrospective Cohort Study.

Related Experiment Videos

Coxsackie-virus heart-disease

Related Concept Videos

Related Articles